Search results for "Pharmaceutical Industry"
showing 10 items of 54 documents
Governance forms drivers in bio-pharmaceutial inter-firm relationships
2012
Networking benefits are acknowledged by many studies in the industrial organization and strategic management fields; transaction cost theory agency and property right theory provide the economic foundations to the market-hierarchy dilemma; while Resource based-view (RBV), relational and evolutionary theories provide the strategic foundation of the inter-firm relationships. All this theoretical strands investigate reasons that push firms to formalize their relationship in different governance structures. The bio-pharmaceutical industry has the characteristics to offer to the potential partners both exploitation or exploration alliances benefits. In particular some elements play a “pivot” rol…
Drivers influencing the governance of inter-firm relationships in the biopharmaceutical industry: an empirical survey in the Italian context
2013
This paper focuses on factors influencing the choice of the governance form in inter-firm relationships (IFRs) between pharmaceutical and biotechnology companies. By reviewing the relevant literature on transaction cost economics, property right theory, real option and resources-based view, we located some drivers that might influence such relationships and we formulated a set of hypotheses linking them to governance forms. Such a theoretical framework has been empirically tested through a survey conducted among the Italian companies associated to Farmindustria. Empirical results provide some interesting insights on how shaping bio-pharmaceutical deals; we found that the developmental stage…
Latvijas aptieku bezrecepšu medikamentu un uztura bagātinātāju mārketinga stratēģijas analīze.
2022
Maģistra darba mērķis ir balstoties uz teorijas apskatu un iegūto datu analīzi, izdarīt secinājumus par Latvijas lielāko aptieku ķēžu mārketinga stratēģiju, kā arī izveidot priekšlikumus mārketinga stratēģijas uzlabošanai. Darba gaitā autors analizēja lielākās Latvijas aptieku ķēdes un noteica potenciālus mārketinga stratēģijas attīstības virzienus. Analīzes rezultāti liecina par homogēnu mārketinga stratēģiju piekopšanu Latvijas lielāko aptieku ķēžu vidū, kas izteikti redzama vides mārketinga izmantošanā; vairums aptieku tīklu pēdējo gadu laikā palielinājušas investīcijas tiešsaistes mārketingā. Autors secina, ka būtiskas investīcijas unikalitātes (produktu, pakalpojumu, u.c. dimensijās) d…
Estabilidad de antocianinas durante el almacenamiento de jugos de arándanos
2016
Resumen: Antecedentes: Los arándanos y productos de arándano tienen alto valor nutricional, especialmente por su alto contenido de antocianinas. Estas son potentes antioxidantes y poseen alta capacidad de secuestrar radicales libres. Así, los arándanos y productos de arándanos han resultado atractivos para los consumidores interesados en alimentos funcionales. Sin embargo, los tratamientos térmicos y posterior almacenamiento de productos alimenticios influyen en el contenido de antocianinas. La cinética de degradación de las antocianinas puede ser evaluada desde una perspectiva termodinámica, basada en funciones como energía libre, entalpía, entropía y energía de activación. Objetivos: Se e…
Latvijas zāļu tirgus salīdzinājumā ar Eiropas attīstītajām valstīm
2021
Darba autore : Latvijas universitātes Biznesa, vadības un ekonomikas fakultātes bakalaura līmeņa programmas Biznesa vadība, apakšprogrammas Organizāciju vadība studente Diāna Klote. Darba vadītāja: Dr. ekon., prof. Daina Šķiltere. Darba nosaukums: Latvijas zāļu tirgus salīdzinājumā ar Eiropas attīstītajām valstīm. Pārskats par galvenajiem rezultātiem un secinājumiem: Salīdzinot Latvijas zāļu tirgu ar Igaunijas, Lietuvas, Francijas un Vācijas farmācijas tirgiem, tika secināts, ka Latvija atrodas labā šīs nozares attīstības stadijas periodā un nozarei valstī tuvāko gadu laikā ir iespējas sasniegt vēl augstāku līmeni. Lai tas notiktu Latvijas vadošajiem farmācijas uzņēmumiem ir jāturpina iegul…
Potential of ‘Omics’ Technologies for Implementation in Research on Phytotherapeutical Toxicology
2012
Abstract High toxicity is the most common reason why new agents drop out of drug development in the pharmaceutical industry. There is hope that toxicogenomics facilitates the early detection of toxic effects and their molecular mechanisms of action during preclinical studies to remove potentially toxic substances from the development. Herbal remedies consist of mixtures of different herbs, which represent a considerable source of heterogeneity and toxicity. They may be caused by botanical misidentification, contamination with pesticides, heavy metals, organic solvents, microbials and radioactivity. Intentional faked herbal products may contain chemical drugs or hormones. Approaches to apply…
What Do Academic Investigators Want and Get from Preclinical Collaboration with the Pharmaceutical Industry?
2015
BIOPHARMACEUTICAL ALLIANCES AND COMPETITION: A REAL OPTIONS GAMES APPROACH
2013
The competitive landscape where pharmaceutical and biotechnology companies operate has changed radically due to a scientific/technological progress that has revolutionised the process by which drugs are developed. In fact, pharmaceutical industry more and more relies on advances in biochemistry and molecular biology. As a consequence, the number of partnerships between pharmaceutical and biotech firms has grown significantly. Research contributions addressing the biopharmaceutical alliances design have also focused on the optimal timing to sign a partnership. In this paper, we introduce and analyse the effect of competition in biotechnology industry by modelling the decisions of whether and…
R&D ALLIANCE TIMING IN THE BIOPHARMACEUTICAL INDUSTRY: A REAL OPTIONS GAME APPROACH.
How strategic needs influence alliance formation and their governance modes: An empirical study in the Italian biopharmaceutical industry
2011
Firms enter strategic alliances for various reasons, and the motives behind formation of these alliances are one of main research subjects in the management field. The large literature on the issue has highlighted how alliances answer to a strategic need for collaboration that is the need to improve competitive strength through collaboration agreements. However, the study here addresses the strategic need perspective to alliances under a more specific point of view. We question what kind of competitive strengths firms aim at acquiring through inter-firm relationships. By reviewing of the most relevant literature on the issue we assume that alliances respond to three principal strategic need…